Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian CancerEllen L. Goode, Naveena Singh, Matthew S. Block et al.|JAMA Oncology|2017Cited by 409
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer RiskPooja Middha, Jonine D. Figueroa, Nasim Mavaddat et al.|JNCI Journal of the National Cancer Institute|2020Cited by 74
Prediction and clinical utility of a contralateral breast cancer risk modelDaniele Giardiello, Laura J. van’t Veer, Alison M. Dunning et al.|Breast Cancer Research|2019Cited by 40
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association ConsortiumAnna Morra, Sileny Han, Audrey Jung et al.|Cancer Epidemiology Biomarkers & Prevention|2021Cited by 40
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S. Block, Georgia Chenevix‐Trench, Robert A. Vierkant et al.|Mayo Clinic Proceedings|2018Cited by 30